Introduction {#S1}
============

Alcohol dependence (AD) is a psychiatric disorder that is the 3^rd^ most common preventable cause of death and morbidity in the US ([@R14]). The World Health Organization (WHO) estimated the number of alcohol users to be 2 billion worldwide in the year 2002. In an estimate of factors responsible for global disease burden, alcohol contributed 3.2% of all deaths in the year 2000 (<http://www.who.int/substance_abuse/facts/global_burden/en/)>.

Despite advances in AD research, treatment completion and relapse rates remain substantial ([@R9]). The etiology of AD is complex: once use is initiated, the vulnerability to become dependent on alcohol is modulated by genetic and environmental factors as well as by their interactions. The contribution of genetic factors to AD is substantial, with a heritability of 50--64% ([@R31]). Thus, it is important to identify genes involved in the neurobiological pathways mediating alcohol's reinforcing effects and associated with its abuse liability.

Dampening of the stress response is one of the main mechanisms by which alcohol exerts its reinforcing effects ([@R27]). Animal and human studies suggest a central role for substance P (SP) in mediating the stress response ([@R13]). The biological actions of SP are exerted primarily through neurokinin receptor subtype 1 (NK1R; also called tachykinin receptor 1; TACR1), which is densely expressed in the brain structures implicated in stress pathways ([@R11]), as well as in non-neuronal peripheral tissues including gut, joints, muscle, and cutaneous tissues ([@R26]; [@R1]). Antagonists of NK1R are effective in treating depression, anxiety, and post-operative and chemotherapy-induced emesis ([@R25]). Recently, a reduction in the craving for alcohol in anxious alcoholics was reported in response to the NK1R blocker LY686017 ([@R10]).

The NK1R protein is encoded by *NK1R*, located on chromosome 2p13.1 spanning about 151 kb with five exons. According to the NCBI database (<http://www.ncbi.nlm.nih.gov>), *NK1R* is transcribed into at least four mRNA variants, resulting from alternative promoter usage, differential splicing, or both. The mRNA variants are putatively translated into four functional NK1R isoforms that may possess different affinities for SP. Additionally, the expression of these isoforms appears to be tissue specific. For example, so far, only the two longest isoforms of mRNA have been found in the human brain ([@R5]; [@R16]). Therefore, naturally occurring polymorphisms at or near promoter or splice regions may determine NK1R density, altering SP-mediated signaling.

The objective of the current study was to determine whether genetic variants of *NK1R* are associated with AD by performing a case-control association study in a sample of Caucasian AD and control subjects.

Materials and Methods {#S2}
=====================

Participants {#S3}
------------

A total of 608 unrelated Caucasian subjects were recruited from central-southern USA. Participants provided written informed consent on a form approved by all involved institutional review boards. Of these subjects, 271 were treatment-seeking persons with AD, and 337 were controls. Numbers of subjects recruited at each recruitment site are provided in [Table 1](#T1){ref-type="table"}. All AD subjects were recruited as part of pharmacotherapy trials for the treatment of alcohol dependence. Alcohol dependence was diagnosed using the Structured Clinical Interview ([@R7]) for *Diagnostic and Statistical Manual of Mental Disorders, 4th edition* ([@R2]) Axis I Disorders. In addition, all the AD subjects had a score of ≥ 8 on the *Alcohol Use Disorders Identification Test (AUDIT)* ([@R3]), which assesses the personal and social harm after alcohol consumption, reported drinking of ≥ 21 standard drinks/week for women and ≥ 30 standard drinks/week for men during the 90 days prior to enrollment, and negative urine toxicologic screen for narcotics, amphetamines, or sedative-hypnotics at enrollment. Abstinence was not an entry criterion. Subjects who had current Axis I psychiatric diagnoses other than alcohol or nicotine dependence; significant alcohol withdrawal symptoms \[revised clinical institute withdrawal assessment for alcohol scale ([@R28]) score \>15\]; clinically significant physical abnormalities identified at physical examination, electrocardiogram recording, hematologic assessment, biochemistry tests including serum bilirubin concentration and urinalysis; pregnant or lactating state; treatment for alcohol dependence ≤30 days prior to enrollment; and mandated incarceration or employment loss for not receiving alcohol treatment were excluded. All control subjects were selected from a large genetic study on tobacco smoking to match ethnicity and age of the AD subjects and were recruited primarily from the Mid-South States during 1999--2005 ([@R4]; [@R19]). All control individuals were screened for a history of substance use disorders and other Axis I psychiatric disorders, and subjects who were positive were excluded. Additionally, in the control group, none of the subjects reported having consumed \> 4 standard drinks in total, during the 90 days prior to enrollment. Self-reported ethnicity data was collected for both control and AD individuals at study entry. The demographic characteristics of both AD and control subjects are presented in [Table 1](#T1){ref-type="table"}.

DNA extraction, SNP selection and genotyping {#S4}
--------------------------------------------

Ten milliliters of blood was drawn from each subject to obtain white blood cells. The DNA was extracted using a Gentra Puregene® kit (QIAGEN Inc., Valencia, CA). We selected 11 SNPs from the National Center for Biotechnology Information (NCBI) dbSNP database (<http://www.ncbi.nlm.nih.gov/SNP/>) on the basis of high heterozygosity (minor allele frequency ≥ 0.05) and chromosomal position for maximum uniform coverage of the gene. Detailed information on SNP locations, chromosomal positions, allelic variants, minor allele frequency, and primer/probe sequences is summarized in [Table 2](#T2){ref-type="table"}. Additionally, 24 Ancestry Informative Markers (AIMs) were genotyped in all AD and control subject DNA samples to test for population stratification. The primary reasons for us to use these AIMs are that they have been demonstrated to have high frequency differences for South American/European ancestry and European/West African ancestry based on a survey study for a genome-wide ancestry marker panel and are suggested to be essential markers for population stratification investigation ([@R20]). Information on these marker SNPs are given in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}.

All SNP assays were carried out with the *Taq*Man® SNP genotyping assay in the 384-well microplate format (Applied Biosystems, Foster City, CA). Polymerase chain reaction (PCR) conditions were 50°C for 2 min, 95°C for 10 min, 30 cycles of 95°C for 25 s, and 60°C for 1 min. Each reaction was carried out with 10ng of DNA from each subject, and SNP-specific control samples were added to each 384-well plate to ensure the quality of the assays. Allelic discrimination analyses were performed with an ABI PRISM® 7900HT instrument (Applied Biosystems) using sequence detection software.

Statistical Analysis {#S5}
--------------------

We assessed linkage disequilibrium (LD) and haplotype blocks with all 11 SNPs in cases and controls separately, using Haploview (v. 4.1) (Gabriel et al., 2000). The associations between individual SNPs and AD were analyzed with Unphased (v. 3.0.13) software ([@R6]) which calculates a maximum-likelihood ratio statistic allowing for covariate adjustments. An association of a SNP with AD was considered significant only if its *p* value was less than the corrected *p* value based on the SNP spectral decomposition (SNPSpD) approach for multiple testing ([@R23]). As calculated by SNPSpD, the corrected statistically significant *p* value for 11 SNP analyses was set at *p*=0.006. The associations between haplotypes and AD were analyzed with Haplo Stats (v. 1.2.1) software (<http://mayoresearch.mayo.edu/mayo/research/biostat/schaid.cfm>). We defined a "major haplotype" as one with a frequency of more than 5% in either the AD or the control samples. Bonferroni correction was used to calculate the corrected *p* value for the haplotype analyses. In both individual SNP and haplotype association analyses with AD, using Unphased and Haplo Stats programs respectively, age and sex were used as modifiers and site IDs where each AD and control subject was recruited initially, were used as confounders in all our association analyses. Furthermore, to test for possible moderating effects of each covariate on the observed associations between AD and individual SNPs, we employed a general linear model (GLM) in SAS (v. 9.1) that included age, sex and center IDs as main effects as well as their interactions with individual SNPs.

The program Structure 2.2 (<http://www.stats.ox.ac.uk/~pritch/home.html>) was used to assess the population stratification in the subjects enrolled at the three sites. Simulation parameters were set to 10,000 burn-ins, 10,000 iterations and *K* was set to 3 (for three recruitment sites).

Results {#S6}
=======

Individual SNP association analyses with AD {#S7}
-------------------------------------------

Genotypic distributions of all 11 SNPs conformed to the Hardy-Weinberg equilibrium with the smallest *p* value being 0.102. The genotypic and allelic frequencies for each SNP in both case and control samples are shown in [Table 3](#T3){ref-type="table"}. Individual SNP-based association analyses performed with Unphased (v. 3.0.13) software, using a statistical model incorporating age, sex and site IDs as covariates, revealed that the genotypic and allelic frequencies were significantly different in the case and control samples for SNPs rs2111375 (*p*=0.0454) and rs6715729 (*p*=0.0012). After correction for multiple testing, only SNP rs6715729 remained significant. When the frequency of the G allele, which is the minor allele for rs6715729 in the AD sample, was compared with the frequency of the G allele in the control group, the difference was statistically significant (*p*=0.0006) with an odds ratio (OR) of 6.13 (95% CI= 4.06, 9.23). As revealed by SAS GLM model, the interaction between rs6715729 and site IDs was significant at *p* \< 0.0001; notably, the individual SNP rs6715729 effect on AD also remained significant (*p*= 0.0002) in this GLM model, confirming the genetic effect of rs6715729 on AD.

Haplotype analyses {#S8}
------------------

We employed Haploview to calculate pair-wise correlation coefficients (*r*^2^, the squared total linkage disequilibrium divided by the product of the allelic frequencies at both loci) to detect haplotype blocks among all 11 SNPs according to the criteria defined by [@R8]. As shown in [Figure 1](#F1){ref-type="fig"}, we detected three haplotype blocks in the control sample. These blocks, each comprising two-SNP combinations, were located at the 5' end of the gene, around exon 2, and at the 3' end of the gene: rs2111375--rs6715729, 1 kb; rs735668-rs6741029, 17kb; rs1106855-rs881, 2kb. In contrast, we did not detect any haplotype blocks in the AD sample.

Next, using Haplo Stats, we performed haplotype-based association analyses in several ways: First, within each Haploview defined LD block comprising of 2 SNPs as shown in [Figure 1](#F1){ref-type="fig"}; and secondly, with all possible three-SNP combinations within the three Haploview defined LD blocks. Also, we performed a haplotype analysis with all 27 possible three-SNP haplotype combinations formed by the 11 SNPs that were genotyped in this study. The haplotype analyses within the three 2-SNP LD blocks, detected only one Haploview-defined LD block (rs735668 and rs6741029) to be significantly associated with AD (global association test *p*=1.439×10^−9^). Our second approach, the haplotype analyses with all 6 SNPs within the 3 Haploview defined LD blocks, yielded four major haplotypes formed by a three-SNP combination of rs6715729-rs7356680-rs6741029 ([Table 4](#T4){ref-type="table"}). These three SNPs were located in adjacent LD blocks within a distance of 80,533bp in the *NK1R* gene and comprised of SNP rs6715729 that was significantly associated with AD at individual level. Therefore we considered 3-SNP combination formed by rs6715729-rs7356680-rs6741029 to be more informative than the 2-SNP combination formed by rs7356680 and rs6741029 alone. Of the four major haplotypes formed by rs6715729-rs7356680-rs6741029, two were negatively associated with AD (G-C-G, G-A-G), whereas the other two were positively associated with AD (A-A-G, G-C-T). After correcting for multiple testing, only the two positively associated haplotypes remained significant. (The corrected statistically significant *p* value for a three-SNP haplotype analysis was set at *p*=0.006.) The A-A-G and G-C-T haplotypes together accounted for 17.5% of the pooled sample (29.4% of the AD sample and 8.8% of the control sample). The observed frequency differences for haplotypes A-A-G (18.5% in AD and 8.1% in controls) and G-C-T (10.9% in AD and 0.8% in controls) in the AD and control samples were significantly different (χ^2^ =2.8953, p=0.0038 and χ^2^ =6.0062, p=1.8992×10^−9^, respectively) with corresponding ORs of 1.89 (95% CI=1.16, 3.11) for A-A-G and 11.31 (95% CI= 3.62, 35.35) for G-C-T. Therefore, the odds of becoming dependent on alcohol were more than 1 in subjects carrying either of these two haplotypes. Hence, they were named "risk haplotypes." The SNPs that formed the two risk haplotypes were located in exon 1 and intronic regions on either side of exon 2 spanning about 82 kb.

Population stratification for subjects enrolled at the three study sites was assessed with 24 AIM SNP markers. Results from program Structure showed no evidence for the presence of population admixture in both case and control subjects included in this study. Therefore, all 608 subjects were included in association analyses with AD, both at individual and haplotype levels.

Discussion {#S9}
==========

In this study, we provide the first evidence for an association of *NK1R* polymorphisms with AD in Caucasian individuals. After genotyping for 11 SNPs spanning the gene, we detected SNP rs6715729 and two haplotypes, A-A-G and G-C-T formed by rs6715729-rs7356680-rs6741029, that were significantly associated with AD. The allele frequencies of rs6715729, a synonymous SNP in exon 1, differed significantly in the AD and control samples. In the AD sample, allele A of rs6715729 was significantly more frequent than that in the control sample. The frequency of the A allele in our control sample was in agreement with the findings of an independent study by [@R25] that showed the A allele of rs6715729 to be less frequent than the G allele in a sample of 100 healthy individuals of Caucasian descent.

Moreover, we detected two haplotypes, G-C-T and A-A-G, formed by rs6715729-rs735668-rs6741029, that were significantly associated with AD; and both showed a significant risk effect on the development of AD. The first risk haplotype, A-A-G, was two-fold more common (OR=1.89; 95% CI=1.16, 3.11) in the AD than in the control sample. The second risk haplotype, G-C-T, was present predominantly in the AD sample (10.92% compared with 0.75% of the control sample) with a likelihood of about 11-fold higher in AD subjects than in controls (OR=11.31; 95% CI: 3.62, 35.35). By comparing allele composition in the two haplotypes, we found that unlike the A-A-G haplotype, the G-C-T risk haplotype G allele at rs6715729 showed a negative association with AD individually. On the other hand, the other two SNPs in the two haplotypes, rs735668 and rs6741029, did not show a significant association with AD individually. This suggests that the risk effects of these two haplotypes are conferred by a combination of alleles among the three SNPs. Indeed, haplotype analyses identify a combination(s) of SNPs that modulate each others' individual effects to shape the overall modest effects caused by single genes in the etiology of complex traits such as AD ([@R33]). In this context, another possibility is the presence of an unknown functional *cis*-acting polymorphism(s) in the region extending from SNPs rs735668 to rs6741029 that is associated with AD.

To our knowledge, this is the first study to investigate associations between AD and *NK1R* SNPs. The strength of our findings is enhanced by the differences in LD structures in the cases and controls. In the control sample, the SNPs that constitute the two risk haplotypes were in adjacent haplotype blocks; interestingly, these blocks were not seen in the AD sample, suggesting that this region may have undergone selection. Furthermore, the region of *NK1R* extending from rs6715729 to rs6741029 corresponds to the 5' end of *NK1R* primary mRNA, which is translated into the N-terminal region through the end of the 2^nd^ extracellular loop of NK1 receptors ([@R1]). The NK1 receptors are 7-transmembrane domain G-protein coupled with three extracellular loops, three intracellular loops, an intracellular C terminus, and an extracellular N terminus. Among the many properties of the 5' end portion of NK1 receptors important in SP signal transduction, the presence of a binding site for SP has been reported involving the 2^nd^ extracellular loop ([@R18]). Although none of the SNPs included in the two risk haplotypes affect the amino acid sequence of a protein, they could affect SP signal transduction by altering receptor density through alternative splicing of *NK1R* mRNA. Given the large size of the gene and the relatively low density of the SNPs we have genotyped, future genotyping studies should be aimed at identifying causative loci within this region.

There are several limitations to this study. First, the controls and cases were recruited at three geographic locations. To reduce the potential geographic effects on our association results, we included center ID as a covariate in all the association analyses. Additionally, we performed an analysis for genetic structure with 24 unlinked AIMs to exclude ethnic admixture within the Caucasian sample studied. Although the number of AIMs genotyped in our study was not as large as we wish, we do think they are sufficient for our purpose here. This is because: 1) 24 AIMs have been reported to be as effective in estimating continental population ancestry as identified with more than 90 AIMs ([@R15]) and 2) self-reported ethnicity usually is consistent with classification based on molecular markers ([@R32]). The second main limitation in our study is that the control sample had a relatively higher female population than the AD sample. This issue was addressed by including sex as a covariate in all the analyses. Third, our cases were a population of AD individuals who were motivated to decrease or cease their alcohol consumption. Therefore, this cohort may be more motivated and perhaps less dense in drinking pathophysiology than AD individuals derived from community samples ([@R30]).

Numerous studies have affirmed that the product of *NK1R*, the receptor, together with its substrate SP, modulates mesocorticolimbic dopamine (DA) release, which is essential for the reward involved in AD ([@R22]; [@R12]). The SP-receptor system also is implicated in the etiology of other psychiatric disorders such as anxiety, depression, or dysfunctional behavioral patterns observable prior to the onset of AD ([@R12]). Although NK1Rs play a vital role in the etiology of these psychiatric disorders that are comorbid with AD, to date, association studies on *NK1R* polymorphisms with psychiatric disorders in general are sparse. In a cohort of German subjects, [@R11] showed that four SNPs located across *NK1R* were not associated with suicidal behavior but may modulate aggression features. Nominal associations were found with panic disorder ([@R17]) and bipolar disorder ([@R24]); lack of an association of *NK1R* SNPs was reported with autism ([@R21]) and dyslexia ([@R25]). To our knowledge, associations of *NK1R* polymorphisms with any substance use disorders have not been examined.

In summary, we detected SNP rs6715729 and two haplotypes in *NK1R* that were significantly associated with AD in Caucasians. These results strongly indicate that *NK1R* is involved in the etiology of AD. In consideration of the relatively small sample size, more replication is greatly needed in a larger sample of both Caucasian and other ethnic samples. Furthermore, more molecular studies are needed to identify the mechanism(s) by which these genetic variants affect the development of AD.

Supplementary Material {#SM}
======================

This study was funded by grants from the National Institute on Alcohol Abuse and Alcoholism to B.A.J. (Grants 7 U10 AA011776-10, 1 N01 AA001016-000, 7 R01 AA010522-12, and 5 R01 AA012964-06) and N.A.-D. (Grant 5 K23 AA000329-06) and from the National Institute on Drug Abuse to M.D.L. (Grants R01 DA012844 and 5 R01 DA013783).

We appreciate the skilled technical assistance of the staff at the South Texas Addiction Research and Technology Center, Department of Psychiatry, The University of Texas Health Science Center at San Antonio, and the Department of Psychiatry and Neurobehavioral Sciences, University of Virginia. We also are grateful to Dr. Xiang-Yang Lou for his expert advice and Eva Jenkins-Mendoza, BS, for her service as project coordinator.

**Disclosure/Conflict of Interest**

Related to this report, authors Seneviratne, Ait-Daoud, Ma, Chen and Li have nothing to disclosure. Prof. Johnson currently serves as a consultant to Johnson & Johnson (Ortho-McNeil Janssen Scientific Affairs, LLC), Transcept Pharmaceuticals, Inc., Organon, ADial Pharmaceuticals, and Eli Lilly and Company.

![Linkage disequilibrium analysis of *NK1R* SNPs in Caucasian alcohol dependent and control samples. Values in squares are r^2^ numbers.](nihms116772f1){#F1}

###### 

Demographics of AD and control samples used in this study

                                      AD subjects     Control subjects
  ----------------------------------- --------------- ------------------
  Total number                        271             337
  San Antonio, Texas                  189             4
  Charlottesville, Virginia           82              0
  Jackson, Mississippi                0               333
  Male/female                         196/75          127/210
  Mean age (yr ± SD)                  46.16 ± 13.09   46.43 ± 14.58
  Mean age of onset of AD (yr ± SD)   30.13 ± 11.49   NA

###### 

Information on *NK1R* SNPs genotyped in the current study

  SNP number   dbSNP ID    Location within the gene    Physical Location   Alleles   ABI SNP assay ID
  ------------ ----------- --------------------------- ------------------- --------- ------------------
  1            rs2111375   Intergenic at 5′ end        54,243,815          G/A       C_2679170_10
  2            rs6715729   Silent mutation on Exon 1   54,241,665          G/A       C_25473413_10
  3            rs3771860   Intron 1                    54,231,673          T/G       C_27514344_10
  4            rs3821319   Intron 1                    54,205,876          C/G       C_26138472_10
  5            rs735668    Intron 1                    54,178,981          C/A       C_2679114_10
  6            rs6741029   Intron 2                    54,161,132          G/T       C_2974531_20
  7            rs4853105   Intron 2                    54,140,523          A/T       C_29680163_10
  8            rs4439987   Intron 2                    54,103,043          A/G       C_1227902_10
  9            rs727156    Intron 3                    54,096,144          T/C       C_580584_10
  10           rs1106855   Intron 4                    54,093,924          A/G       C_1227897_10
  11           rs881       3′-UTR                      54,092,366          C/G       C_11466393_10

###### 

Genotype and allele frequencies of *NK1R* SNPs for alcohol-dependent and control subjects

  db SNP ID   Frequencies from HapMap-CEU data set      Genotype count (frequency) from the present study   Allele count (frequency)                                                                                                          
  ----------- ----------------------------------------- --------------------------------------------------- -------------------------- --------- --------- --------- --------- --------- ------------ --------- --------- --------- --------- --------------
  rs211137                                                                                                                                                                                                                                    
  5           GG=0.518                                                                                                                                                                                                                        
  1 = G       GA=0.393                                  G=0.714                                             147                        102       17        183       126       21        **0.0454**   396       136       492       168       **0.0155**
  2 = A       AA=0.089                                  A=0.286                                             (0.553)                    (0.383)   (0.064)   (0.555)   (0.382)   (0.064)   (0.744)      (0.256)   (0.745)   (0.255)             
  rs671572                                                                                                                                                                                                                                    
  9           [‡](#TFN2){ref-type="table-fn"}GG=0.130                                                                                                                                                                                         
  1 = G       GA=0.391                                  [‡](#TFN2){ref-type="table-fn"}G=0.326              63                         129       73        92        164       76        **0.0012**   255       275       348       316       ***0.0006***
  2 = A       AA=0.478                                  A=0.674                                             (0.238)                    (0.487)   (0.275)   (0.277)   (0.494)   (0.229)   (0.481)      (0.519)   (0.524)   (0.476)             
  rs377186                                                                                                                                                                                                                                    
  0           TT=0.491                                                                                                                                                                                                                        
  1 = T       TG=0.404                                  T=0.693                                             153                        91        18        185       132       16        0.4853       397       127       502       164       0.2544
  2 = G       GG=0.105                                  G=0.307                                             (0.584)                    (0.347)   (0.069)   (0.556)   (0.396)   (0.048)   (0.758)      (0.242)   (0.754)   (0.246)             
  rs382131                                                                                                                                                                                                                                    
  9           CC=0.186                                                                                                                                                                                                                        
  1 = C       CG=0.475                                  C=0.424                                             30                         98        137       50        148       136       0.6243       158       372       248       420       0.4708
  2 = G       GG=0.339                                  G=0.576                                             (0.113)                    (0.370)   (0.517)   (0.150)   (0.443)   (0.407)   (0.298)      (0.702)   (0.371)   (0.629)             
  rs735668                                                                                                                                                                                                                                    
  1 = C       CC=0.281                                                                                                                                                                                                                        
  2 = A       CA=0.474                                  C=0.518                                             73                         123       68        77        165       93        0.2129       269       259       319       351       0.1393
              AA=0.246                                  A=0.482                                             (0.277)                    (0.466)   (0.258)   (0.230)   (0.493)   (0.278)   (0.509)      (0.491)   (0.476)   (0.524)             
  rs674102                                                                                                                                                                                                                                    
  9           GG=0.458                                                                                                                                                                                                                        
  1 = G       GT=0.373                                  G=0.644                                             100                        112       43        138       154       41        0.3023       312       198       430       236       0.2172
  2 = T       TT=0.169                                  T=0.356                                             (0.392)                    (0.439)   (0.169)   (0.414)   (0.462)   (0.123)                (0.611)   (0.388)   (0.646)   (0.354)   
  rs485310                                                                                                                                                                                                                                    
  5           TT=0.167                                                                                                                                                                                                                        
  1 = T       TA=0.333                                  T=0.333                                             32                         102       128       34        149       148                    166       358       217       445       0.0665
  2 = A       AA=0.500                                  A=0.667                                             (0.122)                    (0.389)   (0.489)   (0.103)   (0.450)   (0.447)   0.1212       (0.317)   (0.683)   (0.328)   (0.672)   
  rs443998                                                                                                                                                                                                                                    
  7           GG=0.220                                                                                                                                                                                                                        
  1 = G       GA=0.542                                  G=0.492                                             58                         133       62        69        142       121       0.4375       249       257       280       384       0.3739
  2 = A       AA=0.237                                  A=0.508                                             (0.229)                    (0.526)   (0.245)   (0.208)   (0.428)   (0.364)   (0.492)      (0.508)   (0.422)   (0.578)             
  rs727156    TT=0.768                                                                                                                                                                                                                        
  1 = T       TC=0.196                                  T=0.866                                             187                        67        9         219       96        16        0.7694       441       85        534       128       0.7225
  2 = C       CC=0.036                                  C=0.134                                             (0.711)                    (0.255)   (0.034)   (0.662)   (0.290)   (0.048)   (0.838)      (0.162)   (0.807)   (0.193)             
  rs110685                                                                                                                                                                                                                                    
  5           GG=0.593                                                                                                                                                                                                                        
  1 = G       AG=0.339                                  G=0.763                                             149                        90        21        196       117       22        0.8343       388       132       509       161       0.8255
  2 = A       AA=0.068                                  A=0.237                                             (0.573)                    (0.346)   (0.081)   (0.585)   (0.349)   (0.066)   (0.746)      (0.254)   (0.760)   (0.240)             
  rs881                                                                                                                                                                                                                                       
  1 = G       GG=0.719                                                                                                                                                                                                                        
  2 = C       GC=0.263                                  G=0.851                                             184                        59        10        221       93        19        0.9394       427       79        535       131       0.7564
              CC=0.018                                  C=0.149                                             (0.727)                    (0.233)   (0.040)   (0.664)   (0.279)   (0.057)   (0.844)      (0.156)   (0.803)   (0.197)             

HapMap-CEU - Utah residents with ancestry from northern and western Europe, studied in the International HapMap project.

European American descent, submitted to NCBI dbSNP data base from Perlegen Sciences Inc.

\- Chi-square P value for the statistical model that compared genotypic frequencies of alcoholic and control groups with covariate adjustments.

\- Chi-square P value for the statistical model that compared minor allele frequency in alcoholic group and frequency of the same allele in control group with covariate adjustments.

Statistically significant *P* values (before correcting for multiple testing) are shown in bold letters, and *P* values significant after correction for multiple testing are shown in bold italics.

###### 

Association results of major haplotypes formed by SNPs rs6715729, rs735668, and rs6741029 with AD

  Haplotype     *Hapo-score*   P value               Haplotype frequency   Odds ratio                                                   
  ------------- -------------- --------------------- --------------------- -------------- -------------- -------------- --------------- ---------------
  G-C-G         −2.5405        0.0111                0.2051                0.2346         0.1580         0.4824         0.7641          1.2103
  G-A-G         −2.3559        0.0184                0.0737                0.0995         0.0478         0.3415         0.6192          1.1227
  A-A-T         −1.5829        0.1134                0.1301                0.1598         0.0921         0.4229         0.7184          1.2203
  G-A-T         −1.3526        0.1761                0.1778                0.1826         0.1657         0.5411         0.8205          1.2441
  A-C-G         0.2575         0.7968                0.2265                0.2303         0.2222         NA             1.0000          NA
  ***A-A-G***   ***2.8953***   ***0.0038***          ***0.1267***          ***0.0805***   ***0.1846***   ***1.1552***   ***1.8938***    ***3.1045***
  ***G-C-T***   ***6.0062***   ***1.8992×10^−9^***   ***0.0486***          ***0.0075***   ***0.1092***   ***3.6194***   ***11.3113***   ***35.3498***

global-stat = 59.2790; df = 7; p-val = *2.1024 ×10^−10^*

Statistically significant *P* values (after correcting for multiple testing) for individual haplotype frequency differences in AD and control sample are shown in bold italics.
